HU9201929D0 - Process for the production of imidazo-diazepines - Google Patents
Process for the production of imidazo-diazepinesInfo
- Publication number
- HU9201929D0 HU9201929D0 HU9201929A HU9201929A HU9201929D0 HU 9201929 D0 HU9201929 D0 HU 9201929D0 HU 9201929 A HU9201929 A HU 9201929A HU 9201929 A HU9201929 A HU 9201929A HU 9201929 D0 HU9201929 D0 HU 9201929D0
- Authority
- HU
- Hungary
- Prior art keywords
- diazepines
- imidazo
- production
- Prior art date
Links
- BMGXAZCDDYTVFV-UHFFFAOYSA-N imidazo[4,5-c]diazepine Chemical class C1=CN=NC2=NC=NC2=C1 BMGXAZCDDYTVFV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH179191 | 1991-06-17 | ||
| CH114092 | 1992-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9201929D0 true HU9201929D0 (en) | 1992-08-28 |
Family
ID=25686778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9201929A HU9201929D0 (en) | 1991-06-17 | 1992-06-10 | Process for the production of imidazo-diazepines |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5387585A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0519307A3 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH078869B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR930000517A (cg-RX-API-DMAC10.html) |
| AU (1) | AU655472B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2069382A1 (cg-RX-API-DMAC10.html) |
| CZ (1) | CZ185092A3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI922827A7 (cg-RX-API-DMAC10.html) |
| HU (1) | HU9201929D0 (cg-RX-API-DMAC10.html) |
| IE (1) | IE921945A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL102175A0 (cg-RX-API-DMAC10.html) |
| IS (1) | IS3878A (cg-RX-API-DMAC10.html) |
| NO (1) | NO922367L (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ243091A (cg-RX-API-DMAC10.html) |
| TW (1) | TW201311B (cg-RX-API-DMAC10.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW349100B (en) * | 1994-11-11 | 1999-01-01 | Hoffmann La Roche | Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines |
| JPH10298078A (ja) * | 1997-05-06 | 1998-11-10 | Mitsubishi Chem Corp | 抗不安薬 |
| TWI239333B (en) | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
| US6686352B2 (en) * | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
| EP1461323B1 (en) * | 2001-06-12 | 2013-10-09 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| MX2007004250A (es) * | 2004-10-12 | 2007-06-12 | Hoffmann La Roche | Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos. |
| MX2007004640A (es) * | 2004-10-20 | 2007-06-08 | Hoffmann La Roche | Derivados de benzodiazepina sustituidos con halogeno. |
| BRPI0519991A2 (pt) | 2004-10-20 | 2009-04-07 | Hoffmann La Roche | derivados de imidazo-benzodiazepina |
| BRPI0515800A (pt) | 2004-12-14 | 2008-08-05 | Hoffmann La Roche | imidazo-benzodiazepinas tetracìclicas como moduladores de receptores de gaba |
| WO2007042421A1 (en) | 2005-10-11 | 2007-04-19 | F. Hoffmann-La Roche Ag | Imidazo benzodiazepine derivatives |
| US9322831B2 (en) | 2008-09-23 | 2016-04-26 | The Johns Hopkins University | DDX3 as a biomarker for cancer and methods related thereto |
| JP5802872B2 (ja) * | 2008-09-23 | 2015-11-04 | ザ ジョンズ ホプキンズ ユニヴァーシティー | 縮合ジイミダゾジアゼピン化合物並びにその使用及び製造方法 |
| AU2014240289B2 (en) * | 2008-09-23 | 2015-12-03 | The Johns Hopkins University | Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| WO2012068161A1 (en) | 2010-11-15 | 2012-05-24 | Agenebio, Inc. | Pyridazine derivatives, compositions and methods for treating cognitive impairment |
| HRP20181052T1 (hr) | 2013-09-06 | 2018-09-07 | Aurigene Discovery Technologies Limited | Derivati 1,2,4-oksadiazola kao imunomodulatori |
| MX381561B (es) | 2013-12-20 | 2025-03-12 | Agenebio Inc | Derivados de benzodiazepina, composiciones, y métodos para tratar el deterioro cognitivo. |
| KR102708045B1 (ko) | 2015-03-10 | 2024-09-23 | 오리진 온콜로지 리미티드 | 면역조절제로서의 1,2,4-옥사다이아졸 및 티아다이아졸 화합물 |
| CU20170118A7 (es) * | 2015-03-10 | 2018-02-08 | Aurigene Discovery Tech Ltd | Compuestos de tiadiazol y 1,2,4-oxadiazol 3-sustituidos como inmunomoduladores |
| CN113264939A (zh) * | 2015-06-19 | 2021-08-17 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法 |
| WO2017112777A1 (en) | 2015-12-22 | 2017-06-29 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| BR112019012821A2 (pt) | 2016-12-19 | 2019-11-26 | Agenebio, Inc. | derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo |
| KR102736865B1 (ko) | 2017-06-21 | 2024-12-03 | 샤이 테라퓨틱스 엘엘씨 | 암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물 |
| WO2019061324A1 (en) | 2017-09-29 | 2019-04-04 | Curis Inc. | CRYSTALLINE FORMS OF IMMUNOMODULATORS |
| CN111194308A (zh) | 2017-10-11 | 2020-05-22 | 奥瑞基尼探索技术有限公司 | 3-取代的1,2,4-噁二唑的结晶形式 |
| WO2019087087A1 (en) | 2017-11-03 | 2019-05-09 | Aurigene Discovery Technologies Limited | Dual inhibitors of tim-3 and pd-1 pathways |
| EA202090749A1 (ru) | 2017-11-06 | 2020-08-19 | Ориджен Дискавери Текнолоджис Лимитед | Способы совместной терапии для иммуномодуляции |
| EA202190076A1 (ru) | 2018-06-19 | 2021-09-22 | Эйджинбайо, Инк. | Производные бензодиазепина, композиции и способы лечения когнитивных нарушений |
| US12391705B2 (en) | 2018-12-19 | 2025-08-19 | Shy Therapeutics, Llc | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1143728A (en) * | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
| ZW985A1 (en) * | 1984-01-19 | 1985-08-28 | Hoffmann La Roche | Imidazodiazepine derivatives |
| US4897392A (en) * | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
| DK443589D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK41191D0 (da) * | 1991-03-07 | 1991-03-07 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og anvendelse |
-
1992
- 1992-05-15 TW TW081103807A patent/TW201311B/zh active
- 1992-05-25 CA CA002069382A patent/CA2069382A1/en not_active Abandoned
- 1992-06-10 HU HU9201929A patent/HU9201929D0/hu unknown
- 1992-06-10 NZ NZ243091A patent/NZ243091A/en unknown
- 1992-06-10 EP EP19920109745 patent/EP0519307A3/de not_active Withdrawn
- 1992-06-11 IL IL102175A patent/IL102175A0/xx unknown
- 1992-06-12 JP JP4179406A patent/JPH078869B2/ja not_active Expired - Lifetime
- 1992-06-12 AU AU18234/92A patent/AU655472B2/en not_active Ceased
- 1992-06-12 IS IS3878A patent/IS3878A/is unknown
- 1992-06-16 KR KR1019920010394A patent/KR930000517A/ko not_active Withdrawn
- 1992-06-16 CZ CS921850A patent/CZ185092A3/cs unknown
- 1992-06-16 NO NO92922367A patent/NO922367L/no unknown
- 1992-06-17 FI FI922827A patent/FI922827A7/fi not_active Application Discontinuation
- 1992-07-01 IE IE194592A patent/IE921945A1/en not_active Application Discontinuation
-
1993
- 1993-11-15 US US08/153,234 patent/US5387585A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR930000517A (ko) | 1993-01-15 |
| IL102175A0 (en) | 1993-01-14 |
| AU655472B2 (en) | 1994-12-22 |
| NO922367D0 (no) | 1992-06-16 |
| CA2069382A1 (en) | 1992-12-18 |
| NZ243091A (en) | 1994-11-25 |
| AU1823492A (en) | 1992-12-24 |
| FI922827A0 (fi) | 1992-06-17 |
| JPH078869B2 (ja) | 1995-02-01 |
| EP0519307A3 (en) | 1993-04-21 |
| CZ185092A3 (en) | 1993-12-15 |
| IE921945A1 (en) | 1992-12-30 |
| US5387585A (en) | 1995-02-07 |
| IS3878A (is) | 1992-12-18 |
| TW201311B (cg-RX-API-DMAC10.html) | 1993-03-01 |
| EP0519307A2 (de) | 1992-12-23 |
| JPH05202051A (ja) | 1993-08-10 |
| NO922367L (no) | 1992-12-18 |
| FI922827A7 (fi) | 1992-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9200392D0 (en) | Process for the production of new beta-amino-alpha-hydroxycarboxyl-acid | |
| HU9201929D0 (en) | Process for the production of imidazo-diazepines | |
| HU913595D0 (en) | Process for the production of tnf-muteines | |
| HU913664D0 (en) | Process for the production of indian- and kinoline derivatives | |
| HU912005D0 (en) | Process for the production of aminobenzodiazepines | |
| HU913290D0 (en) | Process for the production of cyuclodextrines | |
| HU910151D0 (en) | Process for the production of substituted 2-chloride-pyridines | |
| HU9200933D0 (en) | Process for the production of kinoline derivatives | |
| HUT64763A (en) | Process for the production of cyclobutane-purines | |
| SG47726A1 (en) | Process for the manufacture of 2-alkoxymethylacrolein | |
| HU913280D0 (en) | Process for the production of 8-chloro-kinoline derivatives | |
| HU910937D0 (en) | Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives | |
| HU9201260D0 (en) | Process for the production of new indole- and dihydrokinoline derivatives | |
| HU9201787D0 (en) | Improved process for the production of glycosil-transpherases | |
| HU9200117D0 (en) | Process for the production of 3'-fluor-pirimidine nucleozides | |
| IL100132A0 (en) | Process for the production of decabromodiphenylalkane | |
| EP0510391A3 (en) | Process for the production of polyphenylenethers | |
| HU910107D0 (en) | Process for the production of fitohemagglutinin | |
| HU9201054D0 (en) | Process for the production of alkenyl-alkanoate-catalysts | |
| HU912132D0 (en) | Process for the production of 16-methylene-17-hydroxy-19-norprogesterone | |
| HU9201095D0 (en) | Process for the production of sulphonyl-carbamides | |
| HU911990D0 (en) | Process for the production of acyl-oxy-methane-sulphonates | |
| HU913554D0 (en) | Process for the production of aryl-sulphonyl-izocyanates | |
| HU914021D0 (en) | Process for the production of new tetrahydro-naphtaline-derivatives | |
| EP0534412A3 (en) | Process for the production of 4-chloro-trichloro-methyl benzene |